Dose Reduction of Lopinavir in Children

This study has been completed.

Sponsor:

Collaborator:

Commission on Higher Education, Ministry of Education

Information provided by:

The HIV Netherlands Australia Thailand Research Collaboration

ClinicalTrials.gov Identifier:

NCT00887120

First received: April 21, 2009

Last updated: April 22, 2009

Last verified: April 2009

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	February 2009
Primary Completion Date:	January 2009 (Final data collection date for primary outcome measure)

No publications provided by The HIV Netherlands Australia Thailand Research Collaboration

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Puthanakit T, van der Lugt J, Bunupuradah T, Ananworanich J, Gorowara M, Phasomsap C, Jupimai T, Boonrak P, Pancharoen C, Burger D, Ruxrungtham K. Pharmacokinetics and 48 week efficacy of low-dose lopinavir/ritonavir in HIV-infected children. J Antimicrob Chemother. 2009 Nov;64(5):1080-6. Epub 2009 Sep 2.

To Top